PI3K/Akt promotes feedforward mTORC2 activation through IKKα

Han C Dan1,2,3, Ricardo J Antonia1, Albert S Baldwin1

  • 1The Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

Oncotarget
|March 31, 2016
PubMed

Insights

Inhibitor of nuclear factor kappa-B kinase-alpha (IKKα) promotes Akt activation by enhancing mTORC2 activity, suggesting IKKα as a potential cancer therapeutic target to inhibit mTORC2 and Akt signaling.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Signaling

Background:

  • Akt is crucial for cell survival, growth, and metabolism, and its dysregulation is common in cancers.
  • Akt activity is regulated by phosphorylation at Thr308 (by PDK1) and Ser473 (by mTORC2 complex).
  • Inhibitor of nuclear factor kappa-B kinase-alpha (IKKα) is known to regulate mTORC1, but its role in Akt activation was unexplored.

Purpose of the Study:

  • To investigate the potential involvement of IKKα in controlling Akt activity.
  • To determine if IKKα's role in Akt activation involves the mTORC2 complex.

Main Methods:

  • Co-immunoprecipitation assays to assess IKKα and mTORC2 association.
  • Western blotting to analyze phosphorylation levels of Akt and downstream targets.
  • Experiments involving IKKα knockdown to evaluate its effect on Akt activation.

Main Results:

  • IKKα associates with mTORC2 in cancer cells, dependent on PI3K/Akt activity.
  • IKKα positively regulates Akt phosphorylation at both Ser473 and Thr308.
  • IKKα enhances mTORC2 kinase activity towards Akt, promoting phosphorylation of FOXO3a and GSK3β.

Conclusions:

  • IKKα acts as a feedforward regulator of mTORC2 and Akt activation.
  • IKKα enhances mTORC2 activity, leading to increased Akt phosphorylation and downstream signaling.
  • IKKα represents a potential therapeutic target for blocking mTORC2 and Akt activation in certain cancers.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K